We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+13.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$736B
AUM Growth
+$118B
Cap. Flow
+$48.5B
Cap. Flow %
6.59%
Top 10 Hldgs %
21.01%
Holding
6,593
New
562
Increased
2,527
Reduced
2,494
Closed
544

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.04B
2
NVDA icon
NVIDIA
NVDA
+$2.69B
3
AVGO icon
Broadcom
AVGO
+$2.06B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.46B
5
META icon
Meta Platforms (Facebook)
META
+$1.36B

Sector Composition

Rank Sector Weight
1 Technology 20.3%
2 Financials 9.61%
3 Consumer Discretionary 7.75%
4 Healthcare 6.29%
5 Communication Services 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRESY
5651
Cresud
CRESY
$795M
$168K ﹤0.01%
+15,740
New +$176K
VGZ icon
5652
Vista Gold
VGZ
$251M
$167K ﹤0.01%
+171,182
New +$167K
ACRV icon
5653
Acrivon Therapeutics
ACRV
$64.2M
$167K ﹤0.01%
140,055
+82,536
+143% +$113K
SILC icon
5654
Silicom
SILC
$229M
$166K ﹤0.01%
10,752
+605
+6% +$8.83K
LUCK
5655
Lucky Strike Entertainment
LUCK
$914M
$165K ﹤0.01%
18,123
-20,631
-53% -$186K
FHTX icon
5656
Foghorn Therapeutics
FHTX
$266M
$164K ﹤0.01%
34,901
-21,431
-38% -$89.6K
LCTX icon
5657
Lineage Cell Therapeutics
LCTX
$269M
$164K ﹤0.01%
180,189
-169,914
-49% -$101K
VTEX icon
5658
VTEX
VTEX
$735M
$163K ﹤0.01%
24,727
-196,031
-89% -$1.15M
CLM icon
5659
Cornerstone Strategic Value Fund
CLM
$2.22B
$162K ﹤0.01%
+20,000
New +$148K
RR icon
5660
Richtech Robotics
RR
$318M
$161K ﹤0.01%
82,805
-149,256
-64% -$314K
MGX icon
5661
Metagenomi Therapeutics
MGX
$44.8M
$161K ﹤0.01%
108,596
+28,732
+36% +$45K
BKKT icon
5662
Bakkt Inc
BKKT
$321M
$160K ﹤0.01%
11,489
-8,825
-43% -$97.4K
INBX icon
5663
Inhibrx
INBX
$1.2B
$158K ﹤0.01%
11,089
-6,076
-35% -$78.5K
XGN icon
5664
Exagen
XGN
$109M
$158K ﹤0.01%
+22,602
New +$137K
AUNA
5665
Auna
AUNA
$375M
$157K ﹤0.01%
25,373
-5,365
-17% -$36K
MFIN icon
5666
Medallion Financial
MFIN
$229M
$157K ﹤0.01%
16,475
-22,539
-58% -$204K
CGEN icon
5667
Compugen
CGEN
$222M
$156K ﹤0.01%
87,511
+29,243
+50% +$43.4K
SNDL icon
5668
Sundial Growers
SNDL
$320M
$155K ﹤0.01%
128,497
-295,820
-70% -$394K
GNSS icon
5669
Genasys
GNSS
$76.1M
$154K ﹤0.01%
89,246
+2,033
+2% +$3.75K
IPSC icon
5670
Century Therapeutics
IPSC
$364M
$154K ﹤0.01%
275,978
+96,343
+54% +$51.7K
NTIC icon
5671
Northern Technologies International Corp
NTIC
$76.2M
$154K ﹤0.01%
20,796
+5,524
+36% +$42.2K
CATO icon
5672
Cato Corp
CATO
$68.3M
$154K ﹤0.01%
54,832
+7,395
+16% +$19.7K
VKQ icon
5673
Invesco Municipal Trust
VKQ
$541M
$154K ﹤0.01%
16,836
CMTL icon
5674
Comtech Telecommunications
CMTL
$50.3M
$153K ﹤0.01%
62,336
+17,743
+40% +$31.9K
NTLA icon
5675
CALL
Intellia Therapeutics
NTLA
$1.49B
$152K ﹤0.01%
16,200

Similar funds

Goldman Sachs's Q2 2025 Portfolio in Review

As of Q2 2025, Goldman Sachs held 6,593 positions worth $736B, up 19% from $618B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Goldman Sachs deployed $48.5B of net new capital in Q2 2025, opening 562 new positions and adding to 2,527 existing holdings. Its largest new stake was Emera Inc: 5,401,728 shares worth $248M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.

  • Goldman Sachs's largest Q2 2025 buy was Emera Inc: 5,401,728 shares worth $248M.
  • Goldman Sachs added most to Tesla in Q2 2025, an estimated $5.04B increase.
  • Goldman Sachs's biggest Q2 2025 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
  • Goldman Sachs fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
  • Goldman Sachs's ten largest holdings make up 21% of its $736B portfolio in Q2 2025.
  • Goldman Sachs opened 562 new positions and closed 544 in Q2 2025.
  • Goldman Sachs's portfolio value rose 19% quarter-over-quarter to $736B.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.